Age (years) | 55.37±13.06 | 54.63±14.25 | 0.829 |
Gender (female, %) | 27 (84.4) | 24 (72.7) | 0.367 |
Body mass index (kg/m2) | 22.58±3.86 | 23.06±4.18 | 0.631 |
Baseline DAS28 score | 6.59±0.44 | 6.34±0.64 | 0.43 |
Diabetes | 3 (9.4) | 6 (18.2) | 0.475 |
Hypertension | 8 (25.0) | 15 (45.5) | 0.12 |
Liver disease | 3 (9.4) | 6 (18.2) | 0.475 |
Kidney disease | 0 (0) | 0 (0) | 0.317 |
Heart disease | 3 (9.4) | 0 (0) | 0.114 |
Pulmonary disease | 4 (12.5) | 3 (9.1) | 0.708 |
Use of other RA medications |
Methotrexate | 23 (71.9) | 18 (54.5) | 0.2 |
Hydroxychloroquine | 26 (81.3) | 18 (54.5) | 0.053 |
Leflunomide | 9 (28.1) | 6 (18.2) | 0.389 |
Ciclosporin | 3 (9.4) | 6 (18.2) | 0.475 |
Sulfasalazine | 2 (6.3) | 0 (0) | 0.238 |
Glucocorticoid use | 18 (56.3) | 24 (72.7) | 0.2 |